Breast cancer statistics, 2015: Convergence of incidence rates between black and white women
暂无分享,去创建一个
[1] D. Parkin. Is the recent fall in incidence of post-menopausal breast cancer in UK related to changes in use of hormone replacement therapy? , 2009, European journal of cancer.
[2] D. Berry,et al. Effect of screening and adjuvant therapy on mortality from breast cancer. , 2006, The New England journal of medicine.
[3] Oguzhan Alagoz,et al. Effects of screening and systemic adjuvant therapy on ER-specific US breast cancer mortality. , 2014, Journal of the National Cancer Institute.
[4] Y. Liao,et al. Misclassification of Survey Responses and Black-White Disparity in Mammography Use, Behavioral Risk Factor Surveillance System, 1995-2006 , 2011, Preventing chronic disease.
[5] C. Perou,et al. Epidemiology of basal-like breast cancer , 2008, Breast Cancer Research and Treatment.
[6] P. Remington,et al. Socioeconomic Status and Survival after an invasive Breast Cancer Diagnosis , 2010, Cancer Epidemiology, Biomarkers and Prevention.
[7] J. Lortet-Tieulent,et al. Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society. , 2015, JAMA.
[8] M. Dieci,et al. Rare breast cancer subtypes: histological, molecular, and clinical peculiarities. , 2014, The oncologist.
[9] Zhao Chen,et al. Ethnicity and breast cancer: factors influencing differences in incidence and outcome. , 2005, Journal of the National Cancer Institute.
[10] K. Altundag,et al. Reproductive and hormonal risk factors for postmenopausal luminal, HER‐2‐overexpressing, and triple‐negative breast cancer , 2009, Cancer.
[11] K. Dookeran,et al. Racial and Ethnic Differences in Breast Cancer Survival: How Much Is Explained by Screening, Tumor Severity, Biology, Treatment, Comorbidities, and Demographics? , 2008 .
[12] J. Heck,et al. Delays in breast cancer diagnosis and treatment by racial/ethnic group. , 2006, Archives of internal medicine.
[13] Amy Y. Chen,et al. Insurance status and stage of cancer at diagnosis among women with breast cancer , 2007, Cancer.
[14] Rebecca Smith-Bindman,et al. Racial and ethnic differences in breast cancer survival , 2008, Cancer.
[15] Disparities in breast cancer outcomes between Caucasian and African American women: a model for describing the relationship of biological and nonbiological factors , 2013, Breast Cancer Research.
[16] S. Gomez,et al. Breast Cancer Mortality in African-American and Non-Hispanic White Women by Molecular Subtype and Stage at Diagnosis: A Population-Based Study , 2015, Cancer Epidemiology, Biomarkers & Prevention.
[17] A. Jemal,et al. Prevalence of Major Risk Factors and Use of Screening Tests for Cancer in the United States , 2015, Cancer Epidemiology, Biomarkers & Prevention.
[18] K. Lunetta,et al. Parity, lactation, and breast cancer subtypes in African American women: results from the AMBER Consortium. , 2014, Journal of the National Cancer Institute.
[19] Plasma carotenoids and breast cancer risk in the Cancer Prevention Study II Nutrition Cohort , 2015, Cancer Causes & Control.
[20] Eric J Feuer,et al. The decrease in breast-cancer incidence in 2003 in the United States. , 2007, The New England journal of medicine.
[21] Charles Kooperberg,et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.
[22] C. Parise,et al. Disparities in race/ethnicity and socioeconomic status: risk of mortality of breast cancer patients in the California Cancer Registry, 2000–2010 , 2013, BMC Cancer.
[23] Victoria L. Cafourek,et al. Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. , 2011, Journal of the National Cancer Institute.
[24] A. Gompel. Breast cancer incidence rates in US women are no longer declining. , 2011, Climacteric : the journal of the International Menopause Society.
[25] C. Perou,et al. How many etiological subtypes of breast cancer: two, three, four, or more? , 2014, Journal of the National Cancer Institute.
[26] G. Colditz,et al. Traditional breast cancer risk factors in relation to molecular subtypes of breast cancer , 2011, Breast Cancer Research and Treatment.
[27] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.
[28] J. Lynch,et al. Trends in Area-Socioeconomic and Race-Ethnic Disparities in Breast Cancer Incidence, Stage at Diagnosis, Screening, Mortality, and Survival among Women Ages 50 Years and Over (1987-2005) , 2009, Cancer Epidemiology Biomarkers & Prevention.
[29] W. Thompson,et al. Risk factors by molecular subtypes of breast cancer across a population-based study of women 56 years or younger , 2011, Breast Cancer Research and Treatment.
[30] Richard J. K. Taylor,et al. The impact of changes in hormone therapy on breast cancer incidence in the US population , 2009, Cancer Causes & Control.
[31] A. Jemal,et al. Breast cancer statistics, 2013 , 2014, CA: a cancer journal for clinicians.
[32] Charles M Perou,et al. Systems biology and genomics of breast cancer. , 2011, Cold Spring Harbor perspectives in biology.
[33] H. Morrison,et al. Breast cancer incidence and hormone replacement therapy in Canada. , 2010, Journal of the National Cancer Institute.
[34] P. Porter,et al. Reproductive factors and risk of estrogen receptor positive, triple-negative, and HER2-neu overexpressing breast cancer among women 20–44 years of age , 2012, Breast Cancer Research and Treatment.
[35] Christian A. Rees,et al. Molecular portraits of human breast tumours , 2000, Nature.
[36] R. Shi,et al. Effects of payer status on breast cancer survival: a retrospective study , 2015, BMC Cancer.
[37] D. Silverman,et al. Cancer incidence and mortality trends among whites in the United States, 1947-84. , 1987, Journal of the National Cancer Institute.
[38] Graham A. Colditz,et al. Trends in breast cancer incidence and mortality in the United States: implications for prevention , 2013, Breast Cancer Research and Treatment.
[39] Steven J. M. Jones,et al. Comprehensive molecular portraits of human breast tumours , 2013 .
[40] J. Ranstam,et al. Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50 302 women with breast cancer and 96 973 women without the disease , 2002, The Lancet.
[41] S. Curtin,et al. Births: final data for 2013. , 2015, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.
[42] M. Yaffe,et al. American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography , 2007, CA: a cancer journal for clinicians.
[43] L. Goldman,et al. Accuracy of Diagnostic Mammography at Facilities Serving Vulnerable Women , 2011, Medical care.
[44] J. Palmer,et al. Postpartum remodeling, lactation, and breast cancer risk: summary of a National Cancer Institute-sponsored workshop. , 2013, Journal of the National Cancer Institute.
[45] Päivi Heikkilä,et al. Subtyping of Breast Cancer by Immunohistochemistry to Investigate a Relationship between Subtype and Short and Long Term Survival: A Collaborative Analysis of Data for 10,159 Cases from 12 Studies , 2010, PLoS medicine.
[46] Ping Sun,et al. Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States. , 2015, JAMA.
[47] P. Kyyrönen,et al. Postmenopausal hormone drugs and breast and colon cancer: Nordic countries 1995-2005. , 2008, Maturitas.
[48] Helen Farrugia,et al. Decrease in breast cancer incidence following a rapid fall in use of hormone replacement therapy in Australia , 2009, The Medical journal of Australia.
[49] P. Rosenberg,et al. Tracking and evaluating molecular tumor markers with cancer registry data: HER2 and breast cancer. , 2014, Journal of the National Cancer Institute.
[50] A. Jemal,et al. Breast Cancer Statistics , 2013 .
[51] M. Paesmans,et al. Update of the evolution of breast cancer incidence in relation to hormone replacement therapy use in Belgium. , 2012, Maturitas.
[52] A. Jemal,et al. Cancer statistics, 2015 , 2015, CA: a cancer journal for clinicians.
[53] O. Olopade,et al. A perfect storm: How tumor biology, genomics, and health care delivery patterns collide to create a racial survival disparity in breast cancer and proposed interventions for change , 2015, CA: a cancer journal for clinicians.
[54] R. Connelly,et al. Analysis of trends in age-adjusted incidence rates for 10 major sites of cancer. , 1972, American journal of public health.
[55] G. Rauscher,et al. Validating Self-Reported Mammography Use in Vulnerable Communities: Findings and Recommendations , 2014, Cancer Epidemiology, Biomarkers & Prevention.
[56] S. Ooi,et al. Disparities in breast cancer characteristics and outcomes by race/ethnicity , 2011, Breast Cancer Research and Treatment.
[57] S. Anand,et al. Declining incidence of breast cancer after decreased use of hormone-replacement therapy: magnitude and time lags in different countries , 2011, Journal of Epidemiology & Community Health.
[58] S. Yao,et al. Parity and breastfeeding among African-American women: differential effects on breast cancer risk by estrogen receptor status in the Women’s Circle of Health Study , 2013, Cancer Causes & Control.
[59] W. Willett,et al. Fruit and vegetable intake and risk of breast cancer by hormone receptor status. , 2013, Journal of the National Cancer Institute.
[60] Jeffrey H Silber,et al. Characteristics associated with differences in survival among black and white women with breast cancer. , 2013, JAMA.
[61] A. Jemal,et al. Breast Cancer Incidence Rates in U.S. Women Are No Longer Declining , 2011, Cancer Epidemiology, Biomarkers & Prevention.
[62] B. Rosner,et al. Plasma carotenoids and risk of breast cancer over 20 y of follow-up. , 2015, The American journal of clinical nutrition.
[63] R. Tamimi,et al. Established breast cancer risk factors and risk of intrinsic tumor subtypes. , 2015, Biochimica et biophysica acta.
[64] A. Olshan,et al. Obesity, body fat distribution, and risk of breast cancer subtypes in African American women participating in the AMBER Consortium , 2015, Breast Cancer Research and Treatment.
[65] E. Feuer,et al. Bias Associated With Self-Report of Prior Screening Mammography , 2009, Cancer Epidemiology Biomarkers & Prevention.
[66] Steven J. M. Jones,et al. Comprehensive molecular portraits of human breast tumors , 2012, Nature.
[67] C. Perou,et al. Defining breast cancer intrinsic subtypes by quantitative receptor expression. , 2015, The oncologist.